Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis?
dopamine agonist
parathormone
restless legs
sleep
vitamin D
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
12
2022
accepted:
16
01
2023
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Non-motor manifestations are the main features of Parkinson's disease (PD). These have been associated with vitamin D abnormalities, but the role of parathormone (PTH) is still obscure. Among the non-motor symptoms of PD, the pathogenesis of restless leg syndrome (RLS) is still debated, but it has been associated with the vitamin D/PTH axis in other disease models. Our study deepens the association between vitamin D and PTH with the prevalence of non-motor symptoms of PD and explores such a relationship in patients reporting leg restlessness. Fifty patients with PD were extensively investigated with motor and non-motor scales. Data on serum levels of vitamin D, PTH, and related metabolites were obtained, and patients were stratified as having vitamin D deficiency or hyperparathyroidism according to standardized criteria. Overall, 80% of patients with PD exhibited low vitamin D levels, and hyperparathyroidism was diagnosed in 45%. The analysis of the non-motor symptoms profile using the non-motor symptom questionnaire (NMSQ) revealed 36% of leg restlessness, a main feature of RLS. This was significantly associated with worse motor symptoms, quality of sleep, and quality of life. Moreover, it was associated with hyperparathyroidism (OR: 3.48) and with PTH levels, independent of vitamin D, calcium/phosphate levels, and motor status. Our results suggest a significant association between the vitamin D/PTH axis and leg restlessness in PD. PTH has a putative role in nociceptive modulation, and previous evidence on hyperparathyroidism has suggested a possible interrelation with RLS. Further investigations are necessary to add PTH to the non-dopaminergic non-motor landscape of PD.
Sections du résumé
Background
UNASSIGNED
Non-motor manifestations are the main features of Parkinson's disease (PD). These have been associated with vitamin D abnormalities, but the role of parathormone (PTH) is still obscure. Among the non-motor symptoms of PD, the pathogenesis of restless leg syndrome (RLS) is still debated, but it has been associated with the vitamin D/PTH axis in other disease models. Our study deepens the association between vitamin D and PTH with the prevalence of non-motor symptoms of PD and explores such a relationship in patients reporting leg restlessness.
Methods
UNASSIGNED
Fifty patients with PD were extensively investigated with motor and non-motor scales. Data on serum levels of vitamin D, PTH, and related metabolites were obtained, and patients were stratified as having vitamin D deficiency or hyperparathyroidism according to standardized criteria.
Results
UNASSIGNED
Overall, 80% of patients with PD exhibited low vitamin D levels, and hyperparathyroidism was diagnosed in 45%. The analysis of the non-motor symptoms profile using the non-motor symptom questionnaire (NMSQ) revealed 36% of leg restlessness, a main feature of RLS. This was significantly associated with worse motor symptoms, quality of sleep, and quality of life. Moreover, it was associated with hyperparathyroidism (OR: 3.48) and with PTH levels, independent of vitamin D, calcium/phosphate levels, and motor status.
Conclusion
UNASSIGNED
Our results suggest a significant association between the vitamin D/PTH axis and leg restlessness in PD. PTH has a putative role in nociceptive modulation, and previous evidence on hyperparathyroidism has suggested a possible interrelation with RLS. Further investigations are necessary to add PTH to the non-dopaminergic non-motor landscape of PD.
Identifiants
pubmed: 36873448
doi: 10.3389/fneur.2023.1113913
pmc: PMC9978794
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1113913Informations de copyright
Copyright © 2023 Marano, Pozzilli, Magliozzi, Tabacco, Naciu, Palermo and Di Lazzaro.
Déclaration de conflit d'intérêts
MM, VP, AM, GT, AN, AP, and VD was employed by the company Fondazione Policlinico Universitario Campus Bio-Medico.
Références
Basic Clin Neurosci. 2017 Mar-Apr;8(2):105-112
pubmed: 28539994
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
Nat Rev Neurosci. 2017 Jul;18(7):435-450
pubmed: 28592904
J Am Soc Nephrol. 1992 Mar;2(9):1423-9
pubmed: 1627764
J Clin Endocrinol Metab. 2014 Mar;99(3):1072-80
pubmed: 24423366
Brain Sci. 2022 Jan 16;12(1):
pubmed: 35053861
Front Neurol. 2020 May 27;11:454
pubmed: 32536905
Clin Endocrinol (Oxf). 2000 Mar;52(3):329-38
pubmed: 10718831
Front Neurol. 2018 Jul 24;9:551
pubmed: 30087647
Peptides. 1993 Mar-Apr;14(2):269-74
pubmed: 8483807
Parkinsonism Relat Disord. 2013 Apr;19(4):426-30
pubmed: 23333538
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Neurology. 2011 Nov 29;77(22):1941-6
pubmed: 22076542
Brain Sci. 2022 Jun 16;12(6):
pubmed: 35741675
World J Surg. 2013 Dec;37(12):2866-71
pubmed: 23959340
Parkinsonism Relat Disord. 2011 Dec;17(10):771-3
pubmed: 21733736
Parkinsonism Relat Disord. 2012 Jan;18(1):54-8
pubmed: 21917501
Surgery. 2005 Apr;137(4):426-30
pubmed: 15800490
Front Endocrinol (Lausanne). 2012 Oct 08;3:121
pubmed: 23060860
Lancet. 2018 Jan 13;391(10116):168-178
pubmed: 28923463
Acta Neurol Scand. 2019 Oct;140(4):274-280
pubmed: 31389003
Cir Cir. 2019;86(1):96-98
pubmed: 30951041
Neurology. 2011 Nov 29;77(22):1936-7
pubmed: 22076545
Sleep Med. 2018 Mar;43:40-46
pubmed: 29482811
Transl Neurodegener. 2012 Feb 27;1(1):6
pubmed: 23211049
Sleep Med. 2013 Dec;14(12):1381-6
pubmed: 24210601